Suppr超能文献

经肛门直肠内括约肌切除术治疗超低位直肠癌的系统评价。

Intersphincteric resection for very low rectal cancer: a systematic review.

机构信息

Department of Surgery, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka, 830-0011, Japan.

出版信息

Surg Today. 2013 Aug;43(8):838-47. doi: 10.1007/s00595-012-0394-3. Epub 2012 Nov 9.

Abstract

Radical surgical treatment for very low rectal cancer near the anus has generally involved abdominoperineal resection. Various sphincter-saving operations have been developed for such tumors to optimize the patients' postoperative quality of life. Current protocols focus on intersphincteric resection (ISR), which differs from conventional hand-sewn coloanal anastomosis (CAA) after low anterior resection. However, the efficacy of ISR remains unclear. The surgical, oncologic, and functional outcomes after intersphincteric resection (ISR) were reviewed. This review of the current literature was conducted by searching the PubMed online database. Articles focusing specifically on conventional hand-sewn CAA were excluded from this study. The mean mortality rate is <2 %, and the mean morbidity rate ranges from 7.7 to 38.3 %. The mean local recurrence rate varies widely from 0 to 22.7 %, with a mean follow-up duration of 40-94 months. The mean disease-free and overall 5-year survival rates are 69-86 and 79-97 months, respectively. Functional outcomes are generally acceptable, but accurate evaluation is extremely difficult due to the absence of unified appraisal methods. ISR appears surgically, oncologically and functionally acceptable. However, more experience and better understanding of the oncology, anal physiology, and pelvic anatomy are necessary to achieve successful outcomes without complications, and to improve patient survival.

摘要

经肛门直肠低位前切除术的保肛手术治疗。为优化患者术后生活质量,针对此类肿瘤,各种保留肛门括约肌的手术应运而生。目前的方案侧重于经括约肌间切除术(ISR),与传统的经肛门直肠低位前切除术后手工缝合的结肠肛管吻合术(CAA)不同。然而,ISR 的疗效尚不清楚。对经括约肌间切除术(ISR)的手术、肿瘤学和功能结果进行了回顾。通过搜索 PubMed 在线数据库进行了本研究的文献综述。本研究排除了专门针对传统手工缝合 CAA 的文章。死亡率平均<2%,发病率平均范围为 7.7%至 38.3%。局部复发率平均为 0%至 22.7%,平均随访时间为 40-94 个月。无病生存率和总 5 年生存率分别为 69-86%和 79-97%。功能结果通常是可以接受的,但由于缺乏统一的评估方法,准确评估极其困难。ISR 在手术、肿瘤学和功能方面似乎是可以接受的。然而,为了实现无并发症的成功结果,并提高患者的生存率,需要更多的经验和对肿瘤学、肛门生理学和骨盆解剖学的更好理解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验